Scientists want to create a production pipeline of a tomato crop enriched with the Parkinson's disease drug L-DOPA, giving patients new access to one of the world's most essential medicines.
The development of the genetically modified (GM) tomato, led by British researchers, has implications for developing nations where access to pharmaceutical drugs is restricted.